Structure

Physi-Chem Properties

Molecular Weight:  264.12
Volume:  290.704
LogP:  5.565
LogD:  3.887
LogS:  -4.015
# Rotatable Bonds:  1
TPSA:  40.46
# H-Bond Aceptor:  2
# H-Bond Donor:  2
# Rings:  3
# Heavy Atoms:  2

MedChem Properties

QED Drug-Likeness Score:  0.492
Synthetic Accessibility Score:  2.47
Fsp3:  0.111
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.941
MDCK Permeability:  1.4793587979511358e-05
Pgp-inhibitor:  0.031
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.005
20% Bioavailability (F20%):  0.51
30% Bioavailability (F30%):  0.957

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.114
Plasma Protein Binding (PPB):  97.71337127685547%
Volume Distribution (VD):  0.577
Pgp-substrate:  1.8280503749847412%

ADMET: Metabolism

CYP1A2-inhibitor:  0.976
CYP1A2-substrate:  0.655
CYP2C19-inhibitor:  0.793
CYP2C19-substrate:  0.103
CYP2C9-inhibitor:  0.666
CYP2C9-substrate:  0.823
CYP2D6-inhibitor:  0.739
CYP2D6-substrate:  0.901
CYP3A4-inhibitor:  0.291
CYP3A4-substrate:  0.157

ADMET: Excretion

Clearance (CL):  8.54
Half-life (T1/2):  0.176

ADMET: Toxicity

hERG Blockers:  0.02
Human Hepatotoxicity (H-HT):  0.035
Drug-inuced Liver Injury (DILI):  0.93
AMES Toxicity:  0.835
Rat Oral Acute Toxicity:  0.667
Maximum Recommended Daily Dose:  0.92
Skin Sensitization:  0.953
Carcinogencity:  0.887
Eye Corrosion:  0.029
Eye Irritation:  0.969
Respiratory Toxicity:  0.877

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC49994

Natural Product ID:  NPC49994
Common Name*:   12-Deoxytanshinquinone B
IUPAC Name:   8-methyl-2-propan-2-ylphenanthrene-1,4-dione
Synonyms:   12-deoxytanshinquinone b
Standard InCHIKey:  XFSVVSSHBNDWTE-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C18H16O2/c1-10(2)15-9-16(19)17-13-6-4-5-11(3)12(13)7-8-14(17)18(15)20/h4-10H,1-3H3
SMILES:  CC(C1=CC(=O)c2c(C1=O)ccc1c2cccc1C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL227129
PubChem CID:   15484930
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO5743 Salvia miltiorrhiza Species Lamiaceae Eukaryota n.a. root n.a. PMID[11374966]
NPO5743 Salvia miltiorrhiza Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[16038550]
NPO5743 Salvia miltiorrhiza Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[17583950]
NPO5743 Salvia miltiorrhiza Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[18855446]
NPO5743 Salvia miltiorrhiza Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[20455578]
NPO5743 Salvia miltiorrhiza Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[21775156]
NPO5743 Salvia miltiorrhiza Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[23286284]
NPO5743 Salvia miltiorrhiza Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[24108414]
NPO5743 Salvia miltiorrhiza Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[27569393]
NPO5743 Salvia miltiorrhiza Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[29185738]
NPO5743 Salvia miltiorrhiza Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[30351923]
NPO5743 Salvia miltiorrhiza Species Lamiaceae Eukaryota n.a. root n.a. PMID[3655791]
NPO5743 Salvia miltiorrhiza Species Lamiaceae Eukaryota roots n.a. n.a. PMID[9834151]
NPO5743 Salvia miltiorrhiza Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO5743 Salvia miltiorrhiza Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO5743 Salvia miltiorrhiza Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO5743 Salvia miltiorrhiza Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO13164 Iris hoogiana Species Iridaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO28189 Metzgeria pubescens Species Metzgeriaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO14253 Bothriocline longipes Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO11003 Euphorbia sancta Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO191 Amaranthus hybr Species Amaranthaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO5743 Salvia miltiorrhiza Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO11814 Asphodeline tenuior Species Asphodelaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO11985 Glycyrrhiza triphylla Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO11487 Senecio madagascariensis Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT196 Cell Line AGS Homo sapiens IC50 = 21600.0 nM PMID[511186]
NPT21802 PROTEIN FAMILY Hypoxia inducible factors; HIF-1-alpha, HIF-2-alpha Homo sapiens IC50 = 15100.0 nM PMID[511186]
NPT21802 PROTEIN FAMILY Hypoxia inducible factors; HIF-1-alpha, HIF-2-alpha Homo sapiens IC50 = 10600.0 nM PMID[511186]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 > 50000.0 nM PMID[511186]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC49994 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.957 High Similarity NPC134882
0.956 High Similarity NPC238219
0.9462 High Similarity NPC239185
0.9462 High Similarity NPC265220
0.9457 High Similarity NPC260233
0.9451 High Similarity NPC155232
0.9451 High Similarity NPC153885
0.9368 High Similarity NPC109514
0.9368 High Similarity NPC476993
0.9362 High Similarity NPC75724
0.9348 High Similarity NPC289883
0.9341 High Similarity NPC133461
0.9239 High Similarity NPC1682
0.9239 High Similarity NPC188844
0.9231 High Similarity NPC173413
0.9231 High Similarity NPC277277
0.9149 High Similarity NPC185208
0.9149 High Similarity NPC219573
0.913 High Similarity NPC284475
0.9121 High Similarity NPC418308
0.9043 High Similarity NPC472880
0.9032 High Similarity NPC59677
0.9032 High Similarity NPC323420
0.9022 High Similarity NPC19256
0.9011 High Similarity NPC157778
0.8901 High Similarity NPC69057
0.8901 High Similarity NPC43945
0.8804 High Similarity NPC267262
0.8791 High Similarity NPC307
0.8791 High Similarity NPC160339
0.8776 High Similarity NPC472879
0.8725 High Similarity NPC470252
0.86 High Similarity NPC247976
0.8526 High Similarity NPC103346
0.8511 High Similarity NPC298115
0.8462 Intermediate Similarity NPC215008
0.8396 Intermediate Similarity NPC470253
0.835 Intermediate Similarity NPC100767
0.8333 Intermediate Similarity NPC329282
0.8318 Intermediate Similarity NPC326664
0.8316 Intermediate Similarity NPC325709
0.8316 Intermediate Similarity NPC113307
0.8273 Intermediate Similarity NPC318173
0.8261 Intermediate Similarity NPC273758
0.8242 Intermediate Similarity NPC145053
0.8242 Intermediate Similarity NPC273033
0.8242 Intermediate Similarity NPC12936
0.8235 Intermediate Similarity NPC472691
0.8235 Intermediate Similarity NPC474866
0.8235 Intermediate Similarity NPC475939
0.8235 Intermediate Similarity NPC471829
0.8224 Intermediate Similarity NPC143768
0.8211 Intermediate Similarity NPC153308
0.8208 Intermediate Similarity NPC265513
0.8148 Intermediate Similarity NPC67377
0.8132 Intermediate Similarity NPC285716
0.8132 Intermediate Similarity NPC71664
0.8132 Intermediate Similarity NPC190567
0.8132 Intermediate Similarity NPC17408
0.8131 Intermediate Similarity NPC280789
0.8131 Intermediate Similarity NPC292834
0.8131 Intermediate Similarity NPC186128
0.8095 Intermediate Similarity NPC203732
0.8077 Intermediate Similarity NPC172483
0.8077 Intermediate Similarity NPC474910
0.8077 Intermediate Similarity NPC134120
0.8056 Intermediate Similarity NPC93287
0.8022 Intermediate Similarity NPC300205
0.8022 Intermediate Similarity NPC151405
0.8022 Intermediate Similarity NPC139901
0.8 Intermediate Similarity NPC472699
0.8 Intermediate Similarity NPC164526
0.8 Intermediate Similarity NPC472700
0.7982 Intermediate Similarity NPC471721
0.7965 Intermediate Similarity NPC232958
0.7959 Intermediate Similarity NPC125226
0.7935 Intermediate Similarity NPC164086
0.7925 Intermediate Similarity NPC472695
0.7925 Intermediate Similarity NPC472696
0.7925 Intermediate Similarity NPC472701
0.7925 Intermediate Similarity NPC472683
0.7912 Intermediate Similarity NPC285470
0.7912 Intermediate Similarity NPC103488
0.7912 Intermediate Similarity NPC2785
0.7912 Intermediate Similarity NPC36342
0.7909 Intermediate Similarity NPC215419
0.7895 Intermediate Similarity NPC252067
0.7885 Intermediate Similarity NPC274443
0.7885 Intermediate Similarity NPC329556
0.787 Intermediate Similarity NPC474057
0.7857 Intermediate Similarity NPC323440
0.7857 Intermediate Similarity NPC222968
0.7857 Intermediate Similarity NPC80605
0.7845 Intermediate Similarity NPC318067
0.7826 Intermediate Similarity NPC272260
0.7802 Intermediate Similarity NPC245966
0.7802 Intermediate Similarity NPC9796
0.7798 Intermediate Similarity NPC66208
0.7798 Intermediate Similarity NPC218855
0.7788 Intermediate Similarity NPC244427
0.7788 Intermediate Similarity NPC222390
0.7768 Intermediate Similarity NPC469843
0.7748 Intermediate Similarity NPC217111
0.7748 Intermediate Similarity NPC474095
0.7742 Intermediate Similarity NPC95868
0.7739 Intermediate Similarity NPC144547
0.7727 Intermediate Similarity NPC471481
0.7719 Intermediate Similarity NPC202015
0.7685 Intermediate Similarity NPC192577
0.7684 Intermediate Similarity NPC39600
0.7684 Intermediate Similarity NPC197581
0.7677 Intermediate Similarity NPC26224
0.7677 Intermediate Similarity NPC303967
0.7677 Intermediate Similarity NPC67585
0.7677 Intermediate Similarity NPC110420
0.7658 Intermediate Similarity NPC130591
0.7658 Intermediate Similarity NPC234637
0.7658 Intermediate Similarity NPC196673
0.7652 Intermediate Similarity NPC988
0.7652 Intermediate Similarity NPC289432
0.7609 Intermediate Similarity NPC179726
0.7596 Intermediate Similarity NPC221825
0.7589 Intermediate Similarity NPC228936
0.7573 Intermediate Similarity NPC226041
0.757 Intermediate Similarity NPC471186
0.7553 Intermediate Similarity NPC477703
0.7545 Intermediate Similarity NPC137315
0.7542 Intermediate Similarity NPC328107
0.7526 Intermediate Similarity NPC123476
0.7524 Intermediate Similarity NPC128248
0.7524 Intermediate Similarity NPC136810
0.7524 Intermediate Similarity NPC112552
0.7524 Intermediate Similarity NPC225079
0.7524 Intermediate Similarity NPC133809
0.7523 Intermediate Similarity NPC318327
0.7522 Intermediate Similarity NPC260886
0.75 Intermediate Similarity NPC58872
0.75 Intermediate Similarity NPC185763
0.75 Intermediate Similarity NPC37914
0.75 Intermediate Similarity NPC83409
0.7476 Intermediate Similarity NPC12695
0.7474 Intermediate Similarity NPC73978
0.7474 Intermediate Similarity NPC100039
0.7456 Intermediate Similarity NPC158157
0.7447 Intermediate Similarity NPC159661
0.7438 Intermediate Similarity NPC478162
0.7438 Intermediate Similarity NPC478165
0.7436 Intermediate Similarity NPC472981
0.7434 Intermediate Similarity NPC93181
0.7434 Intermediate Similarity NPC186933
0.7431 Intermediate Similarity NPC470007
0.7429 Intermediate Similarity NPC476042
0.7414 Intermediate Similarity NPC476645
0.7411 Intermediate Similarity NPC13784
0.7407 Intermediate Similarity NPC167336
0.7404 Intermediate Similarity NPC240042
0.7404 Intermediate Similarity NPC103048
0.7404 Intermediate Similarity NPC156021
0.7391 Intermediate Similarity NPC268930
0.7391 Intermediate Similarity NPC61651
0.7387 Intermediate Similarity NPC291799
0.7377 Intermediate Similarity NPC96024
0.7373 Intermediate Similarity NPC167323
0.7373 Intermediate Similarity NPC269923
0.7368 Intermediate Similarity NPC135730
0.7368 Intermediate Similarity NPC157055
0.7363 Intermediate Similarity NPC54269
0.7363 Intermediate Similarity NPC285679
0.735 Intermediate Similarity NPC77000
0.735 Intermediate Similarity NPC238861
0.7333 Intermediate Similarity NPC145052
0.7282 Intermediate Similarity NPC34243
0.7273 Intermediate Similarity NPC112903
0.7255 Intermediate Similarity NPC475023
0.7255 Intermediate Similarity NPC475059
0.7253 Intermediate Similarity NPC39799
0.7253 Intermediate Similarity NPC226999
0.7253 Intermediate Similarity NPC87099
0.7253 Intermediate Similarity NPC280135
0.7253 Intermediate Similarity NPC135433
0.7253 Intermediate Similarity NPC158028
0.7253 Intermediate Similarity NPC193578
0.7253 Intermediate Similarity NPC1008
0.7253 Intermediate Similarity NPC74458
0.725 Intermediate Similarity NPC51079
0.725 Intermediate Similarity NPC85511
0.7248 Intermediate Similarity NPC105899
0.7245 Intermediate Similarity NPC267704
0.7241 Intermediate Similarity NPC228318
0.7234 Intermediate Similarity NPC3190
0.7234 Intermediate Similarity NPC249018
0.7228 Intermediate Similarity NPC231591
0.7216 Intermediate Similarity NPC230068
0.7213 Intermediate Similarity NPC474106
0.7212 Intermediate Similarity NPC172925
0.7204 Intermediate Similarity NPC307195
0.7203 Intermediate Similarity NPC476225
0.7193 Intermediate Similarity NPC241851
0.719 Intermediate Similarity NPC164014
0.719 Intermediate Similarity NPC295664

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC49994 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9462 High Similarity NPD3495 Discontinued
0.9239 High Similarity NPD7631 Approved
0.913 High Similarity NPD7609 Phase 3
0.8901 High Similarity NPD650 Approved
0.8438 Intermediate Similarity NPD1508 Approved
0.8242 Intermediate Similarity NPD942 Approved
0.8182 Intermediate Similarity NPD1843 Approved
0.8037 Intermediate Similarity NPD4141 Clinical (unspecified phase)
0.7961 Intermediate Similarity NPD1932 Approved
0.7885 Intermediate Similarity NPD1930 Approved
0.7885 Intermediate Similarity NPD1929 Approved
0.7885 Intermediate Similarity NPD1931 Clinical (unspecified phase)
0.785 Intermediate Similarity NPD2329 Discontinued
0.7767 Intermediate Similarity NPD2066 Phase 3
0.7742 Intermediate Similarity NPD1507 Clinical (unspecified phase)
0.7652 Intermediate Similarity NPD5836 Discontinued
0.7589 Intermediate Similarity NPD5951 Approved
0.7478 Intermediate Similarity NPD7009 Phase 2
0.7453 Intermediate Similarity NPD2648 Phase 3
0.7453 Intermediate Similarity NPD2193 Phase 2
0.7451 Intermediate Similarity NPD5122 Clinical (unspecified phase)
0.7436 Intermediate Similarity NPD4879 Approved
0.7391 Intermediate Similarity NPD7610 Discontinued
0.735 Intermediate Similarity NPD7163 Clinical (unspecified phase)
0.735 Intermediate Similarity NPD3412 Clinical (unspecified phase)
0.7308 Intermediate Similarity NPD1989 Approved
0.729 Intermediate Similarity NPD2196 Discontinued
0.7288 Intermediate Similarity NPD7457 Clinical (unspecified phase)
0.7282 Intermediate Similarity NPD1563 Approved
0.7212 Intermediate Similarity NPD688 Clinical (unspecified phase)
0.7212 Intermediate Similarity NPD6049 Phase 2
0.7212 Intermediate Similarity NPD6048 Clinical (unspecified phase)
0.72 Intermediate Similarity NPD1087 Approved
0.72 Intermediate Similarity NPD506 Clinical (unspecified phase)
0.7168 Intermediate Similarity NPD1609 Clinical (unspecified phase)
0.7105 Intermediate Similarity NPD7094 Approved
0.7105 Intermediate Similarity NPD6858 Approved
0.7087 Intermediate Similarity NPD1239 Approved
0.7075 Intermediate Similarity NPD1566 Phase 3
0.7075 Intermediate Similarity NPD1565 Approved
0.7075 Intermediate Similarity NPD1564 Approved
0.7054 Intermediate Similarity NPD6831 Clinical (unspecified phase)
0.7048 Intermediate Similarity NPD1693 Approved
0.7048 Intermediate Similarity NPD4094 Approved
0.7025 Intermediate Similarity NPD4878 Approved
0.7 Intermediate Similarity NPD5909 Discontinued
0.6991 Remote Similarity NPD1317 Discontinued
0.699 Remote Similarity NPD1089 Approved
0.699 Remote Similarity NPD1090 Approved
0.699 Remote Similarity NPD1086 Approved
0.6972 Remote Similarity NPD2171 Approved
0.697 Remote Similarity NPD3971 Phase 1
0.6937 Remote Similarity NPD1677 Discontinued
0.6937 Remote Similarity NPD2192 Approved
0.6937 Remote Similarity NPD2197 Approved
0.6923 Remote Similarity NPD3317 Approved
0.6916 Remote Similarity NPD4657 Approved
0.6916 Remote Similarity NPD4655 Approved
0.6905 Remote Similarity NPD7008 Discontinued
0.6893 Remote Similarity NPD800 Approved
0.6857 Remote Similarity NPD1088 Approved
0.6847 Remote Similarity NPD2577 Clinical (unspecified phase)
0.6847 Remote Similarity NPD1237 Approved
0.6838 Remote Similarity NPD2508 Discontinued
0.6818 Remote Similarity NPD6027 Approved
0.6818 Remote Similarity NPD6024 Approved
0.6792 Remote Similarity NPD1202 Approved
0.6783 Remote Similarity NPD2181 Clinical (unspecified phase)
0.6777 Remote Similarity NPD2345 Approved
0.6774 Remote Similarity NPD6330 Clinical (unspecified phase)
0.6772 Remote Similarity NPD5952 Clinical (unspecified phase)
0.6759 Remote Similarity NPD1099 Approved
0.6759 Remote Similarity NPD1100 Approved
0.6757 Remote Similarity NPD3357 Discontinued
0.6754 Remote Similarity NPD2182 Approved
0.6696 Remote Similarity NPD164 Approved
0.6696 Remote Similarity NPD664 Approved
0.6667 Remote Similarity NPD5734 Clinical (unspecified phase)
0.6667 Remote Similarity NPD7961 Discontinued
0.6667 Remote Similarity NPD3673 Approved
0.6667 Remote Similarity NPD3672 Approved
0.6641 Remote Similarity NPD2754 Discontinued
0.664 Remote Similarity NPD1876 Approved
0.6613 Remote Similarity NPD3972 Approved
0.6589 Remote Similarity NPD5422 Clinical (unspecified phase)
0.6587 Remote Similarity NPD1470 Approved
0.6585 Remote Similarity NPD3836 Clinical (unspecified phase)
0.6571 Remote Similarity NPD5346 Phase 2
0.6571 Remote Similarity NPD5347 Phase 2
0.6562 Remote Similarity NPD4058 Approved
0.6557 Remote Similarity NPD1651 Approved
0.6538 Remote Similarity NPD1874 Clinical (unspecified phase)
0.6532 Remote Similarity NPD6287 Discontinued
0.6532 Remote Similarity NPD1201 Approved
0.6529 Remote Similarity NPD6065 Approved
0.6518 Remote Similarity NPD813 Approved
0.6504 Remote Similarity NPD2932 Approved
0.6496 Remote Similarity NPD8239 Clinical (unspecified phase)
0.6486 Remote Similarity NPD1238 Approved
0.6484 Remote Similarity NPD675 Discontinued
0.6471 Remote Similarity NPD7077 Approved
0.6471 Remote Similarity NPD7076 Approved
0.6465 Remote Similarity NPD227 Approved
0.6465 Remote Similarity NPD225 Approved
0.646 Remote Similarity NPD5700 Clinical (unspecified phase)
0.6457 Remote Similarity NPD3245 Phase 3
0.6457 Remote Similarity NPD3244 Pre-registration
0.6442 Remote Similarity NPD9257 Approved
0.6442 Remote Similarity NPD9259 Approved
0.6429 Remote Similarity NPD3135 Clinical (unspecified phase)
0.6429 Remote Similarity NPD3549 Approved
0.6429 Remote Similarity NPD3550 Clinical (unspecified phase)
0.6429 Remote Similarity NPD3547 Approved
0.6423 Remote Similarity NPD1245 Approved
0.6423 Remote Similarity NPD3025 Approved
0.6423 Remote Similarity NPD3024 Approved
0.6423 Remote Similarity NPD7003 Approved
0.6408 Remote Similarity NPD4544 Approved
0.6406 Remote Similarity NPD4980 Approved
0.6406 Remote Similarity NPD2798 Approved
0.64 Remote Similarity NPD1281 Approved
0.64 Remote Similarity NPD9490 Approved
0.6381 Remote Similarity NPD4793 Discontinued
0.6378 Remote Similarity NPD1482 Clinical (unspecified phase)
0.6371 Remote Similarity NPD3019 Approved
0.637 Remote Similarity NPD5405 Approved
0.637 Remote Similarity NPD5404 Approved
0.637 Remote Similarity NPD5408 Approved
0.637 Remote Similarity NPD5406 Approved
0.6364 Remote Similarity NPD3093 Approved
0.6357 Remote Similarity NPD7084 Phase 3
0.6339 Remote Similarity NPD7798 Approved
0.6336 Remote Similarity NPD2846 Clinical (unspecified phase)
0.6328 Remote Similarity NPD5653 Discontinued
0.6324 Remote Similarity NPD2346 Discontinued
0.632 Remote Similarity NPD3023 Approved
0.632 Remote Similarity NPD3026 Approved
0.6316 Remote Similarity NPD6647 Phase 2
0.6311 Remote Similarity NPD405 Clinical (unspecified phase)
0.6311 Remote Similarity NPD9491 Approved
0.6299 Remote Similarity NPD5158 Clinical (unspecified phase)
0.6299 Remote Similarity NPD5157 Phase 1
0.6299 Remote Similarity NPD5159 Phase 2
0.6296 Remote Similarity NPD1509 Clinical (unspecified phase)
0.629 Remote Similarity NPD4196 Clinical (unspecified phase)
0.6288 Remote Similarity NPD7713 Phase 3
0.6281 Remote Similarity NPD2319 Discontinued
0.6281 Remote Similarity NPD1246 Approved
0.6275 Remote Similarity NPD226 Approved
0.626 Remote Similarity NPD6966 Discovery
0.626 Remote Similarity NPD997 Clinical (unspecified phase)
0.625 Remote Similarity NPD466 Approved
0.625 Remote Similarity NPD4691 Approved
0.625 Remote Similarity NPD1283 Approved
0.625 Remote Similarity NPD5926 Approved
0.624 Remote Similarity NPD4199 Phase 3
0.6224 Remote Similarity NPD4687 Approved
0.6222 Remote Similarity NPD4705 Clinical (unspecified phase)
0.622 Remote Similarity NPD3880 Clinical (unspecified phase)
0.622 Remote Similarity NPD3356 Approved
0.622 Remote Similarity NPD3355 Approved
0.6216 Remote Similarity NPD2895 Discontinued
0.6216 Remote Similarity NPD5206 Clinical (unspecified phase)
0.6204 Remote Similarity NPD9256 Approved
0.6204 Remote Similarity NPD9258 Approved
0.6198 Remote Similarity NPD6010 Discontinued
0.6183 Remote Similarity NPD7055 Discontinued
0.6179 Remote Similarity NPD4574 Approved
0.6179 Remote Similarity NPD4576 Approved
0.6176 Remote Similarity NPD3903 Approved
0.6176 Remote Similarity NPD3979 Approved
0.6176 Remote Similarity NPD3904 Approved
0.6176 Remote Similarity NPD3981 Approved
0.6172 Remote Similarity NPD182 Clinical (unspecified phase)
0.6162 Remote Similarity NPD9716 Approved
0.6161 Remote Similarity NPD5597 Approved
0.6161 Remote Similarity NPD5598 Approved
0.6161 Remote Similarity NPD2487 Clinical (unspecified phase)
0.6154 Remote Similarity NPD4635 Approved
0.6154 Remote Similarity NPD6007 Clinical (unspecified phase)
0.6146 Remote Similarity NPD4137 Phase 3
0.6142 Remote Similarity NPD5618 Discontinued
0.614 Remote Similarity NPD6354 Discontinued
0.614 Remote Similarity NPD5630 Phase 1
0.6136 Remote Similarity NPD6039 Approved
0.6132 Remote Similarity NPD3099 Discontinued
0.6124 Remote Similarity NPD2056 Discontinued
0.6119 Remote Similarity NPD2979 Phase 3
0.6116 Remote Similarity NPD7635 Approved
0.6103 Remote Similarity NPD7541 Clinical (unspecified phase)
0.6091 Remote Similarity NPD4407 Approved
0.6091 Remote Similarity NPD4405 Approved
0.6091 Remote Similarity NPD4408 Approved
0.609 Remote Similarity NPD6766 Clinical (unspecified phase)
0.6087 Remote Similarity NPD4803 Discontinued
0.6087 Remote Similarity NPD2010 Phase 3
0.6087 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6083 Remote Similarity NPD3644 Approved
0.6083 Remote Similarity NPD3643 Approved
0.6083 Remote Similarity NPD5927 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data